SCAN: Evaluation of Imaging of Peripheral Arteries by Optical Coherence Tomography and Intravascular Ultrasound Imaging

Sponsor
Avinger, Inc. (Industry)
Overall Status
Completed
CT.gov ID
NCT03480685
Collaborator
(none)
12
2
1
4.3
6
1.4

Study Details

Study Description

Brief Summary

A non inferiority trial to determine the capability of optical coherence tomography (OCT) imaging to show vessel morphology in comparison to imaging provided by intravascular ultrasound imaging (IVUS).

Condition or Disease Intervention/Treatment Phase
  • Device: IVUS and OCT Imaging
N/A

Detailed Description

Patients requiring diagnostic imaging of peripheral vessels to determine vessel condition and planning treatment strategy will have vessel segments imaged by both OCT and IVUS imaging catheters. The images will be collected into a library and independent readers will rank each image on the quality of vessel morphology and disease.

Study Design

Study Type:
Interventional
Actual Enrollment :
12 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
A Post-market, Multi-vessel Evaluation of the Imaging of Peripheral Arteries for Diagnostic Purposes Comparing Optical Coherence Tomography and Intravascular Ultrasound Imaging
Actual Study Start Date :
May 24, 2018
Actual Primary Completion Date :
Aug 1, 2018
Actual Study Completion Date :
Oct 1, 2018

Arms and Interventions

Arm Intervention/Treatment
Other: IVUS Imaging vs. OCT Imaging

A vessel segment will be imaged with intravascular ultrasound (IVUS). The same vessel segment will be imaged with optical coherence tomography (OCT).

Device: IVUS and OCT Imaging
Use of an imaging catheter

Outcome Measures

Primary Outcome Measures

  1. Visualization of Vessel Morphology: Layered Structure [During the diagnostic imaging procedures, up to 5 minutes]

    The primary endpoint was met when OCT imaging had the equivalent or lower mean score than IVUS imaging when comparing layered structures. Images were scored on a scale from 1 to 4. A lower score means better image quality and a higher score means worse image quality. Scoring Scale for image quality of layered structure: clear differentiation of vessel wall layers; differentiation of 3 wall layers; differentiation of 2 wall layers; no differentiation visible

  2. Visualization of Vessel Morphology: Non-layered Structure [During the diagnostic imaging procedures, up to 5 minutes]

    The primary endpoint was met when OCT imaging had the equivalent or lower mean score than IVUS imaging when comparing non-layered structures. Images were scored on a scale from 1 to 5. A lower score means better image quality and a higher score means worse image quality. Scoring scale for image quality of non-layered structure: 1-Excellent histology-like image quality to 5-unacceptably poor image quality

  3. Visualization of Vessel Morphology: Calcification [During the diagnostic imaging procedures, up to 5 minutes]

    The primary endpoint was met when OCT imaging had the equivalent or lower mean score than IVUS imaging when comparing images for calcification. Images were scored on a scale from 1 to 5. A lower score means better image quality and a higher score means worse image quality. Scoring Scale for image quality for calcification: 1- Excellent histology-like image quality to 5- Unacceptably poor image quality.

  4. Visualization of Vessel Morphology: Stent Structure [During the diagnostic imaging procedures, up to 5 minutes]

    The primary endpoint was met when OCT imaging had the equivalent or lower mean score than IVUS imaging when comparing stent structure. Images were scored on a scale from 1 to 3. A lower score means better image quality and a higher score means worse image quality. Scoring Scale for image quality of Stent Structure: Excellent image; Acceptable image: Unacceptably poor image.

  5. Visualization of Vessel Morphology: Artifacts [During the diagnostic imaging procedures, up to 5 minutes]

    The primary endpoint was met when OCT imaging had the equivalent or lower mean score than IVUS imaging when comparing imaging artifacts. Images were scored on a scale from 1 to 3. A lower score means better image quality and a higher score means worse image quality. Scoring Scale for image quality of artifacts: None; Tolerable/not limiting; Is intense and limits image quality.

  6. Freedom From Adverse Events [On day of diagnostic imaging procedures, up to 1 hour]

    Primary safety endpoint is freedom from diagnostic imaging procedure-related and device-associated adverse events.

Secondary Outcome Measures

  1. Vessel Measurement: Mean Diameter [During the diagnostic imaging procedures, up to 5 minutes]

    Mean diameter measurements include longest and shortest diameter at proximal, middle, and distal locations.

  2. Vessel Measurement: Total Luminal Area [During the diagnostic imaging procedures, up to 5 minutes]

    Total luminal area is measured from the longest diameter at proximal, middle and distal locations.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 90 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • adult

  • suspected vascular disease that might be a candidate for IVUS

  • reference vessel can accommodate imaging catheters

  • successful diagnostic imaging and removal of IVUS catheter with no adverse events

Exclusion Criteria:
  • if female, pregnant or breast-feeding

  • unwilling to give informed consent

Contacts and Locations

Locations

Site City State Country Postal Code
1 Adventis Midwest Health Hinsdale Illinois United States 60521
2 Pottstown Hospital Pottstown Pennsylvania United States 19464

Sponsors and Collaborators

  • Avinger, Inc.

Investigators

  • Study Director: Thomas Lawson, PhD, Avinger, Inc.

Study Documents (Full-Text)

More Information

Publications

None provided.
Responsible Party:
Avinger, Inc.
ClinicalTrials.gov Identifier:
NCT03480685
Other Study ID Numbers:
  • P0986
First Posted:
Mar 29, 2018
Last Update Posted:
Jun 14, 2021
Last Verified:
Jun 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Product Manufactured in and Exported from the U.S.:
No
Additional relevant MeSH terms:

Study Results

Participant Flow

Recruitment Details
Pre-assignment Detail
Arm/Group Title IVUS Imaging vs. OCT Imaging
Arm/Group Description A vessel segment will be imaged with intravascular ultrasound (IVUS). The same vessel segment will be imaged with optical coherence tomography (OCT).
Period Title: Overall Study
STARTED 12
COMPLETED 12
NOT COMPLETED 0

Baseline Characteristics

Arm/Group Title IVUS Imaging vs. OCT Imaging
Arm/Group Description A vessel segment will be imaged with intravascular ultrasound (IVUS). The same vessel segment will be imaged with optical coherence tomography (OCT).
Overall Participants 12
Overall Images 240
Age (years) [Mean (Full Range) ]
Mean (Full Range) [years]
68
Sex: Female, Male (Count of Participants)
Female
2
16.7%
Male
10
83.3%
Race (NIH/OMB) (Count of Participants)
American Indian or Alaska Native
0
0%
Asian
0
0%
Native Hawaiian or Other Pacific Islander
0
0%
Black or African American
1
8.3%
White
11
91.7%
More than one race
0
0%
Unknown or Not Reported
0
0%
Weight (kg) [Mean (Full Range) ]
Mean (Full Range) [kg]
82
Height (cm) [Mean (Full Range) ]
Mean (Full Range) [cm]
176.8
Leg of vessel accessed (Count of Participants)
Right Leg
3
25%
Left Leg
9
75%
Vessel imaged (Percentage of Participants) [Number]
SFA
64
533.3%
Popliteal
36
300%
Mean length of target segment of vessel (cm) [Mean (Full Range) ]
Mean (Full Range) [cm]
24
Number of images containing a specific vessel characteristic to be scored (Images) [Number]
Layered Structure
24
Nonlayered Structure
104
Calcification
40
Stent Structure
21
Artifact
120

Outcome Measures

1. Primary Outcome
Title Visualization of Vessel Morphology: Layered Structure
Description The primary endpoint was met when OCT imaging had the equivalent or lower mean score than IVUS imaging when comparing layered structures. Images were scored on a scale from 1 to 4. A lower score means better image quality and a higher score means worse image quality. Scoring Scale for image quality of layered structure: clear differentiation of vessel wall layers; differentiation of 3 wall layers; differentiation of 2 wall layers; no differentiation visible
Time Frame During the diagnostic imaging procedures, up to 5 minutes

Outcome Measure Data

Analysis Population Description
Twenty-four imaging pairs of the 120 imaging pairs (240 images total) were analyzed for layered structures.
Arm/Group Title IVUS Imaging OCT Imaging
Arm/Group Description Vessel segment imaged with intravascular ultrasound (IVUS). Same vessel segment imaged with optical coherence tomography (OCT).
Measure Participants 12 12
Measure Images 24 24
Mean (95% Confidence Interval) [score on a scale]
1.61
1.49
2. Primary Outcome
Title Visualization of Vessel Morphology: Non-layered Structure
Description The primary endpoint was met when OCT imaging had the equivalent or lower mean score than IVUS imaging when comparing non-layered structures. Images were scored on a scale from 1 to 5. A lower score means better image quality and a higher score means worse image quality. Scoring scale for image quality of non-layered structure: 1-Excellent histology-like image quality to 5-unacceptably poor image quality
Time Frame During the diagnostic imaging procedures, up to 5 minutes

Outcome Measure Data

Analysis Population Description
One hundred and four imaging pairs of the 120 imaging pairs (240 images total) were analyzed for non-layered structures.
Arm/Group Title IVUS Imaging OCT Imaging
Arm/Group Description Vessel segment imaged with intravascular ultrasound (IVUS). Same vessel segment imaged with optical coherence tomography (OCT).
Measure Participants 12 12
Measure Images 104 104
Mean (95% Confidence Interval) [score on a scale]
2.70
1.82
3. Primary Outcome
Title Visualization of Vessel Morphology: Calcification
Description The primary endpoint was met when OCT imaging had the equivalent or lower mean score than IVUS imaging when comparing images for calcification. Images were scored on a scale from 1 to 5. A lower score means better image quality and a higher score means worse image quality. Scoring Scale for image quality for calcification: 1- Excellent histology-like image quality to 5- Unacceptably poor image quality.
Time Frame During the diagnostic imaging procedures, up to 5 minutes

Outcome Measure Data

Analysis Population Description
Forty imaging pairs of the 120 imaging pairs (240 images total) were analyzed for calcification.
Arm/Group Title IVUS Imaging OCT Imaging
Arm/Group Description Vessel segment imaged with intravascular ultrasound (IVUS). Same vessel segment imaged with optical coherence tomography (OCT).
Measure Participants 12 12
Measure Images 40 40
Mean (95% Confidence Interval) [score on a scale]
2.45
2.11
4. Primary Outcome
Title Visualization of Vessel Morphology: Stent Structure
Description The primary endpoint was met when OCT imaging had the equivalent or lower mean score than IVUS imaging when comparing stent structure. Images were scored on a scale from 1 to 3. A lower score means better image quality and a higher score means worse image quality. Scoring Scale for image quality of Stent Structure: Excellent image; Acceptable image: Unacceptably poor image.
Time Frame During the diagnostic imaging procedures, up to 5 minutes

Outcome Measure Data

Analysis Population Description
Twenty-one imaging pairs of the 120 imaging pairs (240 images total) were analyzed for stent structure.
Arm/Group Title IVUS Imaging OCT Imaging
Arm/Group Description Vessel segment imaged with intravascular ultrasound (IVUS). Same vessel segment imaged with optical coherence tomography (OCT).
Measure Participants 12 12
Measure Images 21 21
Mean (95% Confidence Interval) [score on a scale]
1.79
1.43
5. Primary Outcome
Title Visualization of Vessel Morphology: Artifacts
Description The primary endpoint was met when OCT imaging had the equivalent or lower mean score than IVUS imaging when comparing imaging artifacts. Images were scored on a scale from 1 to 3. A lower score means better image quality and a higher score means worse image quality. Scoring Scale for image quality of artifacts: None; Tolerable/not limiting; Is intense and limits image quality.
Time Frame During the diagnostic imaging procedures, up to 5 minutes

Outcome Measure Data

Analysis Population Description
One hundred and twenty imaging pairs (240 images total) were analyzed for artifacts.
Arm/Group Title IVUS Imaging OCT Imaging
Arm/Group Description Vessel segment imaged with intravascular ultrasound (IVUS). Same vessel segment imaged with optical coherence tomography (OCT).
Measure Participants 12 12
Measure Images 120 120
Mean (95% Confidence Interval) [score on a scale]
1.87
1.79
6. Primary Outcome
Title Freedom From Adverse Events
Description Primary safety endpoint is freedom from diagnostic imaging procedure-related and device-associated adverse events.
Time Frame On day of diagnostic imaging procedures, up to 1 hour

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title IVUS Imaging OCT Imaging
Arm/Group Description Vessel segment imaged with intravascular ultrasound (IVUS). Same vessel segment imaged with optical coherence tomography (OCT).
Measure Participants 12 12
Number [Adverse Events]
0
0
7. Secondary Outcome
Title Vessel Measurement: Mean Diameter
Description Mean diameter measurements include longest and shortest diameter at proximal, middle, and distal locations.
Time Frame During the diagnostic imaging procedures, up to 5 minutes

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title IVUS Imaging OCT Imaging
Arm/Group Description Vessel segment imaged with intravascular ultrasound (IVUS). Same vessel segment imaged with optical coherence tomography (OCT).
Measure Participants 12 12
Proximal Location: Longest Diameter
4.7
(1.2)
4.7
(1.0)
Proximal Location: Shortest Diameter
4.0
(1.1)
3.8
(0.9)
Middle Location: Longest Diameter
4.3
(1.0)
4.3
(0.9)
Middle Location: Shortest Diameter
3.7
(1.0)
3.5
(0.9)
Distal Location: Longest Diameter
3.5
(0.9)
3.5
(0.8)
Distal Location: Shortest Diameter
3.0
(0.9)
3.1
(0.8)
8. Secondary Outcome
Title Vessel Measurement: Total Luminal Area
Description Total luminal area is measured from the longest diameter at proximal, middle and distal locations.
Time Frame During the diagnostic imaging procedures, up to 5 minutes

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title IVUS Imaging OCT Imaging
Arm/Group Description Vessel segment imaged with intravascular ultrasound (IVUS). Same vessel segment imaged with optical coherence tomography (OCT).
Measure Participants 12 12
Proximal Location: Luminal area from longest diameter
18.55
(8.8)
17.95
(7.3)
Middle Location: Luminal area from longest diameter
15.36
(6.6)
14.83
(6.3)
Distal Location: Luminal area from longest diameter
10.06
(6.2)
10.26
(5.4)

Adverse Events

Time Frame On day of diagnostic imaging procedures, up to 1 hour
Adverse Event Reporting Description Method of systematic assessment: any adverse events during the diagnostic imaging procedure are recorded.
Arm/Group Title IVUS Imaging OCT Imaging
Arm/Group Description Vessel segment imaged with intravascular ultrasound (IVUS). Same vessel segment imaged with optical coherence tomography (OCT).
All Cause Mortality
IVUS Imaging OCT Imaging
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/12 (0%) 0/12 (0%)
Serious Adverse Events
IVUS Imaging OCT Imaging
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/12 (0%) 0/12 (0%)
Other (Not Including Serious) Adverse Events
IVUS Imaging OCT Imaging
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/12 (0%) 0/12 (0%)

Limitations/Caveats

[Not Specified]

More Information

Certain Agreements

Principal Investigators are NOT employed by the organization sponsoring the study.

There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.

Results Point of Contact

Name/Title Thomas Lawson, PhD
Organization Avinger, Inc.
Phone 650-241-7030
Email tlawson@avinger.com
Responsible Party:
Avinger, Inc.
ClinicalTrials.gov Identifier:
NCT03480685
Other Study ID Numbers:
  • P0986
First Posted:
Mar 29, 2018
Last Update Posted:
Jun 14, 2021
Last Verified:
Jun 1, 2021